SOURCE: MarketResearch.com

MarketResearch.com

April 12, 2011 08:08 ET

Inclusion of Surrogate & Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology

ROCKVILLE, MD--(Marketwire - Apr 12, 2011) - MarketResearch.com has announced the addition of GBI Research's new report "Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology" to their collection of Therapeutic Area market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=6207054

GBI Research, the leading business intelligence provider, has released its latest research "Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints will Ensure Faster Clinical Trials in Oncology," which essentially provides insights into clinical trial endpoints in oncology. The report details the endpoints and application of endpoints in oncological clinical trials. The report also analyzes the major four markets which include the colorectal cancer, prostate cancer, head and neck cancer and ovarian cancer therapeutics markets. It includes the analysis of endpoints of the major marketed products and their profiling. In addition to marketed products, the Phase III and Phase II clinical trials are also analyzed in terms of percentage cases. Analysis of prevailing and upcoming trends and their effects on the market and company profiling of major companies are included in the report.

The report details the endpoints and application of endpoints in Oncology Clinical Trials. The report covers -

  • Data and analysis on the marketed products and analysis of endpoints used for the approval of the product.
  • Analysis of the four major markets, which includes the colorectal cancer, prostate cancer, head and neck cancer and ovarian cancer therapeutics markets.
  • Analysis of the Phase III and Phase II clinical trials in terms of percentage cases. Analysis of terminated trials is also included in this chapter. Only industry sponsored studies are included in the report.
  • Trend Analysis analyzes prevailing and upcoming trends and their effects on the market.
  • Company Profiling talks in detail about the companies which are strong in the market.

The report will help business development and marketing executives who are strategizing their product launches to -

  • Build an effective R&D strategy by identifying the current state of endpoint achieved by the marketed products.
  • Identify the disease unmet needs for the four major cancers and align your pipeline product portfolio to tap the market potential.
  • Improve our future market position by aligning your R&D pipeline to the areas with maximum success potential.
  • Improve your R&D efficiency by reducing research expenditure on unsuccessful endpoints.
  • Develop key strategic initiatives by understanding the key focus of leading companies with strong product pipeline.

For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=6207054

Contact Information

  • Contact:
    Veronica Franco
    MarketResearch.com
    Email Contact
    240.747.3016